Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
Corcept unveils promising survival data from failed phase 2 ALS trial
Fierce Biotech
Thu, 06/5/25 - 09:59 am
Corcept Therapeutics
ALS
clinical trials
dazucorilant
Newsweek acquires Adprime, a healthcare-focused ad platform
Citybiz
Thu, 06/5/25 - 09:57 am
M&A
pharma advertising
Newsweek
Adprime
Ascletis’s daily acne tablet set for China review after Phase III win
Clinical Trials Arena
Thu, 06/5/25 - 09:49 am
Ascletis
China
clinical trials
denifanstat
acne
Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.
BioPharma Dive
Thu, 06/5/25 - 09:46 am
ASCO 2025
Daiichi Sankyo
antibody-drug conjugates
Hiroyuki Okuzawa
Enhertu
Datroway
Questions swirl over who's running the CDC
Axios
Thu, 06/5/25 - 09:44 am
CDC
HHS
MAHA
Robert F Kennedy Jr.
FDA’s Elsa AI is here, and the industry has questions
Pharma Voice
Thu, 06/5/25 - 09:42 am
FDA
artificial intelligence
drug reviews
Elsa
Has mRNA delivered a breakthrough in quest for HIV cure?
Pharmaphorum
Thu, 06/5/25 - 09:40 am
MRNA
HIV
Merck gains U.S. patent office support in Keytruda dispute
MSN/Seeking Alpha
Wed, 06/4/25 - 10:46 pm
Merck
Keytruda
Halozyme Therapeutics
patents
legal
Biotech funding plummets as Trump policies unnerve investors: Jefferies
BioPharma Dive
Wed, 06/4/25 - 10:44 pm
biotech
funding
Donald Trump
investors
Medicare negotiations underway to lower prices for next batch of drugs
NPR
Wed, 06/4/25 - 10:42 pm
drug pricing
Medicare
Inflation Reduction Act
Novo Nordisk
Amgen
Bayer gains key FDA expansion for fast-rising prostate cancer drug Nubeqa
Fierce Pharma
Wed, 06/4/25 - 10:40 pm
Bayer
FDA
prostate cancer
Nubeqa
metastatic castration-resistant prostate cancer
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
Benzinga
Wed, 06/4/25 - 10:38 pm
AnaptysBio
clinical trials
rheumatoid arthritis
rosnilimab
June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Wed, 06/4/25 - 11:26 am
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
CNBC
Wed, 06/4/25 - 11:22 am
Moderna Therapeutics
vaccines
clinical trials
placebo
COVID-19
Robert F Kennedy Jr.
Massachusetts’ life sciences job growth flattens after 10+ years of increases: report
BioSpace
Wed, 06/4/25 - 11:18 am
Massachusetts
jobs
biotech
biotech hubs
CDC official overseeing COVID-19 vaccine recommendations resigns
MSN/CBS
Wed, 06/4/25 - 11:15 am
CDC
Robert F Kennedy Jr.
COVID-19
vaccines
Biotech CEO confidence hits rock bottom amid policy shifts
Pharma Voice
Wed, 06/4/25 - 11:11 am
biotech
biotech CEOs
Pharma CEOs
confidence
Neuralink competitor Paradromics completes first human implant
CNBC
Wed, 06/4/25 - 11:10 am
Medtech
Paradromics
Neuralink
brain implant
epilespy
Vigil's rare brain disease drug flunks phase 2 study, but Sanofi takeover is unaffected
Fierce Biotech
Wed, 06/4/25 - 11:06 am
Vigil Neuroscience
Sanofi
M&A
clinical trials
iluzanebart
Bayer's Vividion secures rights to only clinical-stage covalent WRN inhibitor from partner Roche
Fierce Biotech
Wed, 06/4/25 - 11:04 am
Bayer
Vividion Therapeutics
WRN inhibitor
Roche
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »